| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Articles |
-Induced Parathyroid Hormone-Related Peptide Production in Synovial Fibroblasts of Patients with Rheumatoid Arthritis
Department of Nutrition, Tokyo Metropolitan Institute of Gerontology (T.Y., A.S., Y.K.), Tokyo 173-0015, Japan; Sakamoto Clinic (H.S.), Kagoshima 899-73, Japan; Department of Internal Medicine (T.H.), Department of Orthopaedic Surgery (S.Y.), Tokyo Metropolitan Geriatric Hospital, Tokyo 173-0015, Japan; and Department of Orthopaedic Surgery, School of Medicine, University of Tokyo (H.O.), Tokyo 113-8655
Address all correspondence and requests for reprints to: Yasuko Koshihara, Ph.D., Department of Nutrition, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashi-ku, Tokyo, 173-0015, Japan. E-mail: ykoshi{at}tmig.or.jp
Abstract
Synovial fibroblasts, established in culture from patients with RA,
were treated with proinflammatory cytokines and prostaglandin
E2 (PGE2) for 24 h. These cells enhanced
the production and the messenger RNA expression of PTH-related peptide
(PTHrP) using proinflammatory cytokines, such as interleukin (IL)-1
,
tumor necrosis factor-
without the coordination of other cytokines.
In addition, PGE2 which has been induced with IL-1, also
enhanced the production of PTHrP. The IL-1
-induced PTHrP production
was inhibited by PG H synthetase (Cox) inhibitors, indomethacin, and
also by Cox-2 inhibitor, NS398. The synovial fibroblasts expressed
PGE2 receptor subtypes, EP2, EP3, EP4, but not EP1, as
detected by RT-PCR. Of the PGE2 receptor agonists, EP4
agonist showed the most marked induction of PTHrP, and EP2 agonist
partly induced the production. However, these PGE2
receptors were not induced by the treatment with IL-1
and
PGE2.
These results suggest that induction of PGE2 by IL-1
may
be an important component of the PTHrP production of the inflammatory
process in synovial tissues from patients with RA. These findings are
the first to demonstrate that PGE2 stimulates PTHrP
production, which is mediated mostly by EP2 and EP4 receptors.
This article has been cited by other articles:
![]() |
P. Clark, S. E. Rowland, D. Denis, M.-C. Mathieu, R. Stocco, H. Poirier, J. Burch, Y. Han, L. Audoly, A. G. Therien, et al. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a Selective E Prostanoid Receptor 4 Antagonist, Relieves Joint Inflammation and Pain in Rodent Models of Rheumatoid and Osteoarthritis J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 425 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Godler, A. N. Stein, O. Bakharevski, M. M. L. Lindsay, and P. F. J. Ryan Parathyroid hormone-related peptide expression in rat collagen-induced arthritis Rheumatology, September 1, 2005; 44(9): 1122 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Largo, I Diez-Ortego, O Sanchez-Pernaute, M J Lopez-Armada, M A Alvarez-Soria, J Egido, and G Herrero-Beaumont EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1{beta} in synovial fibroblasts Ann Rheum Dis, October 1, 2004; 63(10): 1197 - 1204. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |